myeloma


Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
Related to myeloma: multiple myeloma

myeloma

a usually malignant tumour of the bone marrow or composed of cells normally found in bone marrow

myeloma

[‚mī·ə′lō·mə]
(medicine)
A primary tumor of the bone marrow composed of any of the bone marrow cell types.
References in periodicals archive ?
Reolysin has demonstrated the ability to effectively kill an array of cancer cells, including myeloma cells.
Anne was diagnosed with Multiple Myeloma in December 2014, shortly after a visit to her GP due to exhaustion.
He is a clinician and researcher with Myeloma UK Research Centre at the institute of Cancer Research in London.
It's thanks to events like this helping to fund research, that there has been a significant PS1,500 boost for charity increase in the number of drugs available to treat myeloma and improve the quality of life for myeloma patients.
Eric Low, Myeloma UK chief executive, said: "This is a huge investment for a cancer organisation of our size and we are confident that it will lead to important benefits for myeloma patients across the UK.
A spokeswoman for Myeloma UK said: "It is the first myeloma treatment to be developed where the balance between clinical effectiveness and sideeffects is excellent.
He has stated: "Thalidomide is not a bad drug, it's just a drug that was badly used, and for the many myeloma patients today who are benefiting from thalidomide, that's a crucial distinction.
Multiple myeloma represents fewer than 2% of all head and neck cancers.
Thalidomide prescribed in gradually increasing doses brought about improvements in 27 of 84 multiple myeloma patients in whom standard treatments had failed, scientists report in the Nov.
The International Myeloma Foundation (IMF) - the oldest and largest foundation dedicated to improving the life and care of myeloma patients - said POMALYST([R]) (pomalidomide) approval by the U.
It was reported yesterday that the organisation has signed an open-access global research partnership with the Structural Genomics Consortium to discover and characterise novel drug targets for myeloma.
Cancer centers from across the country are expected to use Myeloma Health to run tests to determine if a patient has multiple myeloma.